LifeStance Health Group, Inc. Share Price

Equities

LFST

US53228F1012

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 16:27:35 29/04/2024 BST 5-day change 1st Jan Change
6.305 USD +1.69% Intraday chart for LifeStance Health Group, Inc. +7.75% -19.22%
Sales 2024 * 1.22B 97.11B Sales 2025 * 1.38B 110B Capitalization 2.37B 189B
Net income 2024 * -104M -8.29B Net income 2025 * -76M -6.06B EV / Sales 2024 * 2.1 x
Net Debt 2024 * 186M 14.8B Net Debt 2025 * 117M 9.35B EV / Sales 2025 * 1.8 x
P/E ratio 2024 *
-21.8 x
P/E ratio 2025 *
-28.6 x
Employees 9,325
Yield 2024 *
-
Yield 2025 *
-
Free-Float 26.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.69%
1 week+7.75%
Current month+2.51%
1 month+2.02%
3 months-4.02%
6 months+10.77%
Current year-19.22%
More quotes
1 week
5.81
Extreme 5.81
6.39
1 month
5.62
Extreme 5.615
6.47
Current year
4.74
Extreme 4.735
9.20
1 year
4.74
Extreme 4.735
9.59
3 years
4.22
Extreme 4.22
29.81
5 years
4.22
Extreme 4.22
29.81
10 years
4.22
Extreme 4.22
29.81
More quotes
Managers TitleAgeSince
Founder 39 31/12/16
Chief Executive Officer 65 06/09/22
Director of Finance/CFO 55 09/11/22
Members of the board TitleAgeSince
Chief Executive Officer 65 06/09/22
Director/Board Member 50 31/12/16
Director/Board Member 51 31/12/16
More insiders
Date Price Change Volume
29/04/24 6.325 +2.02% 110 717
26/04/24 6.2 +0.65% 647,258
25/04/24 6.16 -0.16% 864,655
24/04/24 6.17 +0.98% 1,397,448
23/04/24 6.11 +4.09% 1,893,754

Delayed Quote Nasdaq, April 29, 2024 at 04:12 pm

More quotes
LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
6.2 USD
Average target price
8.786 USD
Spread / Average Target
+41.70%
Consensus